Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients ...
The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...
According to the company, the lens is the first and only FDA-approved EDOF IOL in the US without a warning regarding loss of contrast sensitivity. Johnson & Johnson announced that the US Food and Drug ...
NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit organization dedicated to eliminating preventable cataract blindness, is featured in Healthier Together, a branded content series ...
Alcon introduces Hydrus Microstent for long-term glaucoma management in India: Our Bureau, Bengaluru Thursday, March 12, 2026, 14:50 Hrs [IST] Alcon, the global leader in eye care ...
Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
In this episode of The OT Podcast, we speak with optometrist turned ophthalmologist, and Newmedica glaucoma lead, Richard Stead ...
Johnson & Johnson (JNJ) wins FDA approval for Tecnis PureSee intraocular lens ((IOL)), giving eye surgeons a new lens option for use in cataract surgery. Read more here.
Johnson & Johnson introduces the TECNIS Odyssey IOL in India, enhancing vision for cataract patients with advanced technology.
TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- On Monday, March 16, people across Canada will rally outside the offices of their local Liberal Members of Parliament. The nationwide Day of Action warns ...
Discover how menopause affects eye health, from dry eyes to vision changes, and the importance of regular eye evaluations.
It has been over a decade since they’ve seen each other, but an entrepreneur and the childhood doctor that gave him the gift of sight reconnected this week in D.C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results